How to Characterize Extracellular Vesicles by Western Blotting

Extracellular vesicles (EVs) are lipid bilayer-enclosed, extracellular structures released by almost all cell types. These vesicles, carrying protein and genetic cargo, play an important role in intercellular communication and are recognized for their potential therapeutic applications. Due to their inherently heterogeneous nature as well as the complexity of biological samples, it is recommended to characterize EVs after isolation.

There are several ways for isolating EVs from biofluids or cell culture conditioned media (e.g. MesenCult™-ACF Plus Medium), such as immunomagnetic separation, differential ultracentrifugation, or size exclusion chromatography (SEC)*. Using EasySep™ Human Extracellular Vesicle Positive Selection Kits or Extracellular Vesicle SEC Columns, researchers can easily isolate and purify human EVs from biofluids—including serum and plasma—and from culture-conditioned media. Once isolated, the isolated particles can be analyzed to confirm that they are indeed EVs and not products of cell fragmentation or other contaminants such as protein complexes or lipoproteins, usually present in biological samples.

Isolated EVs can be characterized by western blotting or immunoblotting, a widely used technique to detect specific protein markers in a sample. Tetraspanin markers such as CD9, CD63, and CD81 are proteins commonly found on EVs across different cell types. Here, we provide a detailed protocol for performing a western blot to detect the presence of such characteristic EV-associated proteins in order to confirm the presence of EVs in the biological sample.

Materials

• 4X Laemmli Sample Buffer (Bio-Rad Catalog #1610747)
• Tris-hydrochloride (Tris-HCl)
• Glycine
• Distilled water (dH₂O)
• 10% Sodium dodecyl sulfate (SDS) in dH₂O
• Methanol (MeOH)
• Bovine serum albumin (BSA)
• TWEEN® 20
See More
• D-PBS (Without Ca++ and Mg++) (Catalog #37350)
• Low-binding microcentrifuge tube (Catalog #38037 or 38090)
• Reducing agent (optional; e.g. 2-mercaptoethanol or dithiothreitol)
• 10% polyacrylamide gel for electrophoresis
• Polyvinylidene difluoride (PVDF) membrane
• Horseradish peroxidase (HRP)- or fluorochrome-conjugated primary antibodies
See Less

Protocol

I. Buffer Preparation

1. Prepare Transfer Buffer by combining the components in the order listed in Table 1. Mix thoroughly.
   
   Table 1. Preparation of Transfer Buffer
   
   
   Component

   Final Concentration

   Amount to Prepare 1L

   Tris-HCl

   48 mM

   5.8 g

   Glycine

   39 mM

   2.9 g

   10% SDS

   0.0375%

   3.75 mL

   dH₂O

   -

   800 mL

   MeOH

   20%

   200 mL
2. Prepare Blocking Buffer by adding the components listed in Table 2. Mix the solution thoroughly after adding each component.
   
   Table 2. Preparation of Blocking Buffer
   
   
   Components

   Final Concentration

   Amount to Prepare 10 mL

   BSA

   5%

   0.5 g

   TWEEN® 20

   0.2%

   20 µL

   PBS

   -

   10 mL
3. Prepare Wash Buffer by adding 1 mL of TWEEN® 20 in 1 L PBS.



II. EV Sample Preparation

4. Isolate EVs using EasySep™ Human Extracellular Vesicle Positive Selection Kits or Extracellular Vesicle SEC Columns.
5. Fully resuspend EVs in residual liquid from the isolation process and adjust to the desired volume. For instance, EVs isolated from 1 mL of plasma can be adjusted to a final volume of 250 µL. Store isolated EVs in a low-binding tube to reduce EV loss to the sample tube. Set aside 30 µL for western blot analysis.
6. Dilute 3 parts sample with 1 part 4X Laemmli Sample Buffer.
   
   
   Note: When blotting for CD9, CD63, and CD81 antibodies, do not add a reducing agent to the Laemmli Sample Buffer, as CD9/CD63/CD81 detection antibodies often recognize the disulfide bond on the antigen's epitope.
   • EV markers other than CD9/CD63/CD81 may require a reducing agent added to Laemmli Sample Buffer. When uncertain, test 4X Laemmli Sample Buffer with and without reducing reagent. To prepare 4X Laemmli Sample Buffer with reducing agent, add 100 µL of 2-mercaptoethanol to 900 µL of 4X Laemmli Sample Buffer, or add dithiothreitol to 4X Laemmli Sample Buffer to a final concentration of 50 mM.
   • If you used EasySep™ to isolate the EVs, the antibodies from EasySep™ Positive Selection Cocktail may be detected by secondary antibodies. In this case, it is recommended to run a small volume of the Positive Selection Cocktail to check for background signals.
7. Heat the samples at 95°C for 5 minutes.



III. SDS-PAGE

8. Load the desired volume (e.g. 35 µL) of samples per well in a 10% polyacrylamide gel.
9. Run SDS-PAGE for 30 minutes at 200 V.
10. Rinse gel twice with distilled water. Incubate gel in cold Transfer Buffer for 15 minutes.



IV. Immunoblotting and Imaging

11. Assemble transfer sandwich as per instrument instruction and then transfer the proteins onto a PVDF membrane.
    
    • If using semi-dry transfer, use 10 V for 30 minutes.
    • If using wet transfer, use 100 V for 60 minutes.
    Note: Use a low-fluorescence PVDF membrane or nitrocellulose membrane for fluorescence imaging.
12. Rinse the membrane twice with PBS and incubate with Blocking Buffer at room temperature for 1 hour.
13. Wash the membrane 2X for 3 - 5 minutes each with Wash Buffer.
14. Dilute primary antibodies in the blocking buffer.
    
    Recommended dilution ranges:

    • CD9: 1:500 - 1:1000
    • CD63: 1:500 - 1:1000
    • CD81: 1:250 - 1:1000
15. Incubate the membrane with HRP- or fluorochrome-conjugated primary antibodies at room temperature for 1 hour.
    
    
    • Alternatively, incubate unconjugated primary antibodies with membrane at room temperature for 1 hour. Wash membrane 3X for 3 - 5 minutes each with Wash Buffer. Incubate membrane with secondary antibodies at room temperature for 1 hour.
16. Wash the membrane 3X for 3 - 5 minutes each with Wash Buffer.
17. To detect signals from HRP-conjugated antibodies, incubate blot with enhanced chemiluminescence (ECL) substrate and image. To detect a signal from fluorochrome-conjugated antibodies, use fluorescence imaging.

Data

Figure 1. Typical Western Blot Analyses of EVs Isolated from Human Plasma and Mesenchymal Stromal Cell (MSC)-Conditioned Medium

The western blot analyses in the above examples show positive isolation of EVs with CD9, CD63, and CD81 tetraspanin markers from (A) human plasma and (B) MSC-conditioned medium using EasySep™ Human Pan-Extracellular Vesicle Positive Selection Kit (Catalog # 17891). Western blots were run under non-reducing conditions.

Related Materials

Highly pure human EVs can be easily obtained—and in as little as 30 minutes—with EasySep™ using immunomagnetic separation. Explore all our products for EV isolation and characterization below.

Products for Isolation of EVs Using Immunomagnetic Separation

Products for Isolation of EVs Using Size Exclusion Chromatography

Products for Characterization of EVs